GU5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Watchlist Manager

Watchlist

Price: 1.42 EUR -1.39% Market Closed

Market Cap: €3.7B

G	Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SWB:GU5	CN
E	EBOS Group Ltd F:EJG	AU
P	PharmaRoth Labs Inc OTC:ROTH	US
S	Synlait Milk Ltd ASX:SM1	NZ
T	Thunder Mountain Gold Inc XTSX:THM	US
Z	Zeda Ltd JSE:ZZD	ZA
	Intermap Technologies Corp F:I9T1	US
	Intermap Technologies Corp TSX:IMP	US

Profitability Summary

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

16%

Sustainable 3Y Average Gross Margin

17%

Declining Gross Margin

18% > 16%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

6% > 4%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

16%

Sustainable 3Y Average Gross Margin

17%

Declining Gross Margin

18% > 16%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

6% > 4%

Low Net Margin

Low 3Y Average Net Margin